胃癌临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 胃癌（国际通用名 gastric cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖胃腺癌、胃食管结合部癌等说法。
正在招募的胃癌新药试验
Delayed Gastric Emptying After Pancreatic Surgery
不适用招募中中国台湾NCT07382791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
I 期 / II 期招募中美国日本NCT07488676Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1
不适用招募中法国NCT06649474XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study
II 期招募中中国NCT06091423Comprehensive Outcomes for After Cancer Health
不适用招募中美国NCT05349227A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
不适用招募中中国NCT07032961H. Pylori Screen-and-treat Study in a Population of Young Adults
不适用招募中CroatiaIrelandLatviaPolandNCT06275204Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
III 期招募中美国NCT07217704A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
不适用招募中中国NCT07547787A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
II 期招募中美国澳大利亚加拿大中国NCT06760819An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II
II 期 / III 期招募中BelarusNCT06232434A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
I 期 / II 期招募中美国澳大利亚加拿大德国NCT04895709
胃癌试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。
查看四条路径与写信模板